Literature DB >> 29443197

Recurrent paradoxical embolic cerebral ischemia after patent foramen ovale closure.

Filippo M Farina1, Claudio Baracchini1.   

Abstract

Entities:  

Year:  2015        PMID： 29443197      PMCID： PMC5764432          DOI： 10.1212/CPJ.0000000000000101

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


× No keyword cloud information.
  6 in total

Review 1.  Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography.

Authors:  M Jauss; E Zanette
Journal:  Cerebrovasc Dis       Date:  2000 Nov-Dec       Impact factor: 2.762

Review 2.  Patent foramen ovale: the known and the to be known.

Authors:  Shelby Kutty; Partho P Sengupta; Bijoy K Khandheria
Journal:  J Am Coll Cardiol       Date:  2012-05-08       Impact factor: 24.094

3.  Closure or medical therapy for cryptogenic stroke with patent foramen ovale.

Authors:  Anthony J Furlan; Mark Reisman; Joseph Massaro; Laura Mauri; Harold Adams; Gregory W Albers; Robert Felberg; Howard Herrmann; Saibal Kar; Michael Landzberg; Albert Raizner; Lawrence Wechsler
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

4.  Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia.

Authors:  C L Shovlin; J E Jackson; K B Bamford; I H Jenkins; A R Benjamin; H Ramadan; E Kulinskaya
Journal:  Thorax       Date:  2007-11-02       Impact factor: 9.139

5.  Frequency and mechanisms of stroke recurrence after cryptogenic stroke.

Authors:  Oh Young Bang; Phil Hyu Lee; Sung Yeol Joo; Jin Soo Lee; In Soo Joo; Kyoon Huh
Journal:  Ann Neurol       Date:  2003-08       Impact factor: 10.422

6.  International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.

Authors:  M E Faughnan; V A Palda; G Garcia-Tsao; U W Geisthoff; J McDonald; D D Proctor; J Spears; D H Brown; E Buscarini; M S Chesnutt; V Cottin; A Ganguly; J R Gossage; A E Guttmacher; R H Hyland; S J Kennedy; J Korzenik; J J Mager; A P Ozanne; J F Piccirillo; D Picus; H Plauchu; M E M Porteous; R E Pyeritz; D A Ross; C Sabba; K Swanson; P Terry; M C Wallace; C J J Westermann; R I White; L H Young; R Zarrabeitia
Journal:  J Med Genet       Date:  2009-06-23       Impact factor: 6.318
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.